173 related articles for article (PubMed ID: 32979897)
21. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?
Hsieh CH; ChangChien CC; Lin H; Huang EY; Huang CC; Lan KC; Chang SY
Gynecol Oncol; 2002 Jul; 86(1):28-33. PubMed ID: 12079296
[TBL] [Abstract][Full Text] [Related]
22. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma.
Ayhan A; Bozdag G; Taskiran C; Gultekin M; Yuce K; Kucukali T
Gynecol Oncol; 2006 Dec; 103(3):902-5. PubMed ID: 16828847
[TBL] [Abstract][Full Text] [Related]
23. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
[TBL] [Abstract][Full Text] [Related]
24. Preoperative prediction of poor prognostic parameters and adjuvant treatment in women with pure endometrioid type endometrial cancer: what is the significance of tumor markers?
Baser E; Gungor T; Togrul C; Turkoglu O; Celen S
Eur J Gynaecol Oncol; 2014; 35(5):513-8. PubMed ID: 25423695
[TBL] [Abstract][Full Text] [Related]
25. Preoperative Pelvic MRI and Serum Cancer Antigen-125: Selecting Women With Grade 1 Endometrial Cancer for Lymphadenectomy.
Sadowski EA; Robbins JB; Guite K; Patel-Lippmann K; Munoz del Rio A; Kushner DM; Al-Niaimi A
AJR Am J Roentgenol; 2015 Nov; 205(5):W556-64. PubMed ID: 26496578
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of transvaginal ultrasonography and CA 125 in the preoperative evaluation of myometrial invasion in endometrial carcinoma.
Alcázar JL; Jurado M; López-García G
Ultrasound Obstet Gynecol; 1999 Sep; 14(3):210-4. PubMed ID: 10550883
[TBL] [Abstract][Full Text] [Related]
27. Preoperative serum CA-125 levels in treating endometrial cancer.
Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
[TBL] [Abstract][Full Text] [Related]
28. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Mar; 148(3):485-490. PubMed ID: 29290489
[TBL] [Abstract][Full Text] [Related]
29. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
30. Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma.
Ebina Y; Sakuragi N; Hareyama H; Todo Y; Nomura E; Takeda M; Okamoto K; Yamada H; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):458-65. PubMed ID: 12027821
[TBL] [Abstract][Full Text] [Related]
31. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.
Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP
PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921
[TBL] [Abstract][Full Text] [Related]
32. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF
Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503
[TBL] [Abstract][Full Text] [Related]
33. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
34. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
35. Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments.
Mitamura T; Watari H; Todo Y; Kato T; Konno Y; Hosaka M; Sakuragi N
J Gynecol Oncol; 2014 Oct; 25(4):301-5. PubMed ID: 25142623
[TBL] [Abstract][Full Text] [Related]
36. Endometrioid adenocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy.
Chee JJ; Ho TH; Tay EH; Low JJ; Yam KL
Ann Acad Med Singap; 2003 Sep; 32(5):670-5. PubMed ID: 14626800
[TBL] [Abstract][Full Text] [Related]
37. Preoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease.
Sebastianelli A; Renaud MC; Grégoire J; Roy M; Plante M
J Obstet Gynaecol Can; 2010 Sep; 32(9):856-860. PubMed ID: 21050518
[TBL] [Abstract][Full Text] [Related]
38. Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kinalski M; Terlikowski SJ
Adv Med Sci; 2016 Mar; 61(1):23-7. PubMed ID: 26344910
[TBL] [Abstract][Full Text] [Related]
39. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
40. Detection of circulating tumour cells may add value in endometrial cancer management.
Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
